Future research should focus on translating these insights into clinical applications, potentially through the development of NET‐targeting or PAI‐1 inhibition strategies, and exploring the broader implications of the NET–PAI‐1–TGF‐β axis in other cancer types to develop more comprehensive cancer treatment approaches. Here, TGFB1 is linked to cancer.